Center for Translational Research, Children's National Research Institute, Washington, DC, 20010, USA.
Center for Genetic Medicine Research, Children's National Research Institute, Washington, DC, 20010, USA.
J Mol Med (Berl). 2023 Sep;101(9):1141-1151. doi: 10.1007/s00109-023-02351-2. Epub 2023 Aug 16.
Autosomal-recessive polycystic kidney disease (ARPKD; MIM #263200) is a severe, hereditary, hepato-renal fibrocystic disorder that causes early childhood morbidity and mortality. Mutations in the polycystic kidney and hepatic disease 1 (PKHD1) gene, which encodes the protein fibrocystin/polyductin complex (FPC), cause all typical forms of ARPKD. Several mouse lines carrying diverse, genetically engineered disruptions in the orthologous Pkhd1 gene have been generated, but none expresses the classic ARPKD renal phenotype. In the current study, we characterized a spontaneous mouse Pkhd1 mutation that is transmitted as a recessive trait and causes cysticliver (cyli), similar to the hepato-biliary disease in ARPKD, but which is exacerbated by age, sex, and parity. We mapped the mutation to Chromosome 1 and determined that an insertion/deletion mutation causes a frameshift within Pkhd1 exon 48, which is predicted to result in a premature termination codon (UGA). Pkhd1 (cyli) mice exhibit a severe liver pathology but lack renal disease. Further analysis revealed that several alternatively spliced Pkhd1 mRNA, all containing exon 48, were expressed in cyli kidneys, but in lower abundance than in wild-type kidneys, suggesting that these transcripts escaped from nonsense-mediated decay (NMD). We identified an AAAAAT motif in exon 48 upstream of the cyli mutation which could enable ribosomal frameshifting, thus potentially allowing production of sufficient amounts of FPC for renoprotection. This mechanism, expressed in a species-specific fashion, may help explain the disparities in the renal phenotype observed between Pkhd1 mutant mice and patients with PKHD1-related disease. KEY MESSAGES: The Pkhd1 mouse expresses cystic liver disease, but no kidney phenotype. Pkhd1 mRNA expression is decreased in cyli liver and kidneys compared to wild-type. Ribosomal frameshifting may be responsible for Pkhd1 mRNA escape from NMD. Pkhd1 mRNA escape from NMD could contribute to the absent kidney phenotype.
常染色体隐性多囊肾病(ARPKD;MIM#263200)是一种严重的遗传性肝-肾纤维囊性疾病,可导致儿童早期发病和死亡。多囊肾病和肝病 1(PKHD1)基因突变导致所有典型的 ARPKD 形式。已经产生了几种携带同源 Pkhd1 基因中不同遗传工程破坏的小鼠系,但没有一种表达经典的 ARPKD 肾脏表型。在本研究中,我们描述了一种自发的小鼠 Pkhd1 突变,该突变作为隐性性状遗传并导致囊性肝(cyl),类似于 ARPKD 的肝胆疾病,但会随着年龄、性别和产次的增加而加重。我们将突变定位到染色体 1 上,并确定插入/缺失突变导致 Pkhd1 外显子 48 内的移码,预计会导致终止密码子(UGA)提前出现。Pkhd1(cyl)小鼠表现出严重的肝脏病理学,但缺乏肾脏疾病。进一步分析表明,几种替代剪接的 Pkhd1 mRNA,都包含外显子 48,在 cyl 肾脏中表达,但丰度低于野生型肾脏,表明这些转录本逃避了无意义介导的衰变(NMD)。我们在 cyl 突变的上游外显子 48 中鉴定出一个 AAAAAT 基序,该基序可能使核糖体移码,从而可能产生足够量的 FPC 进行肾保护。这种以物种特异性方式表达的机制可能有助于解释在 Pkhd1 突变小鼠和与 PKHD1 相关疾病患者之间观察到的肾脏表型差异。关键信息:Pkhd1 小鼠表达囊性肝病,但无肾脏表型。与野生型相比,cyl 肝脏和肾脏中的 Pkhd1 mRNA 表达减少。核糖体移码可能是 Pkhd1 mRNA 逃避 NMD 的原因。PKHD1 mRNA 逃避 NMD 可能导致肾脏表型缺失。